SBP-9881
/ Camino Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 30, 2020
Camino Pharma receives $920K Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health
(Yahoo Finance)
- "Camino Pharma, LLC...has been awarded a two-year, $920K SBIR grant by the National Institute of Mental Health (NIMH) at the National Institutes of Health. The grant will fund a collaborative effort between Camino Pharma, LLC, University of California San Diego (UCSD) and Sanford Burnham Prebys Medical Discovery Institute....The grant will enable the multidisciplinary team of scientists to validate SBP-9881 in two novel rodent models of anhedonia and avolition designed to translate to clinical efficacy."
Grant • Preclinical • CNS Disorders • Depression
1 to 1
Of
1
Go to page
1